EDSA Edesa Biotech: Multiplikator Forward P/S
Edesa Biotech, Inc. (EDSA) develops immune therapies to combat respiratory pathologies through government partnerships. The absence of sales and rising monitoring costs during late-stage trials drive the forward price-to-sales ratio, which currently stands at . The business's financial stability relies entirely on the results of clinical trials for anti-inflammatory drugs.
Rincian analitis perusahaan Edesa Biotech, Inc.
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Utang marang Ekuitas Edesa Biotech, Inc.|EDSA - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Edesa Biotech, Inc.|EDSA - Gunggung utang perusahaan|Utang marang nilai buku Edesa Biotech Corp|EDSA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Edesa Biotech|Rasio cepet edesabiotech.com
- rincian asil keuangan lan kelipatan valuasi:
EDSA - Asil keuangan resik|Bathi sing dikarepake Edesa Biotech, Inc.|EDSA - Kapitalisasi marang bathi|Prakiraan rega marang bathi Edesa|EDSA - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Edesa Biotech Corp|EDSA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Edesa Biotech|EDSA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan edesabiotech.com|EDSA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Edesa Biotech, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:Edesa Biotech (EDSA)
The specific nature of Edesa Biotech, Inc. (EDSA) and its concentration on a limited number of respiratory therapy drugs makes the business extremely sensitive to clinical trial results. An analysis of the forward P/S ratio allows for a comparison of current market capitalization against expected revenue, identifying either unjustified overvaluation or growth potential, which is critical given the company's high dependence on binary development risks.
Pesaing wigati
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ADMA Corp|PTGX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grifols SA GRFS|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio kapitalisasi marang dodolan sing dikarepake Celldex Corp|Multiplikator Forward P/S AUPH (Aurinia Pharmaceuticals)|Multiplikator Forward P/S biocryst.com BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics Inc)|PHVS: Multiplikator Forward P/S|ABCL (AbCellera Corp) - Rasio rega marang prakiraan pendapatan|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|precigen.com (PGEN) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Upstream Bio Corp - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ZBIO (Zenas Corp)|Immunome, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep gossamerbio.com|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|SVRA: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan RIGL (Rigel Pharmaceuticals)|ANAB (anaptysbio.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXS (Astria Therapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc (ENGN)|RAPT - Rasio rega marang prakiraan pendapatan|JBIO (Aerovate Therapeutics Inc) - Kapitalisasi marang prakiraan pendapatan|ACRS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan kyvernatx.com|Multiplikator forward rega marang pendapatan TLSA|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S VTYX|THTX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|ELDN: Kapitalisasi marang prakiraan pendapatan|AGEN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Climb Bio Inc. CLYM|ZURA: Multiplikator Forward P/S|aTyr Pharmaceuticals (ATYR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Adagene Inc|Ikena Oncology, Inc. - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S STTK|EQ (equilliumbio.com) - Rega forward marang dodolan|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|Multiplikator Forward P/S Immunic Therapeutics IMUX|ATRA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Adicet Bio, Inc.|CELU (Celularity Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S INmune Bio Corporation|Multiplikator forward rega marang pendapatan BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SABS (SAB Biotherapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Akari Therapeutics PLC (AKTX)|ENLV - Rasio rega marang prakiraan pendapatan|Q32 Bio Inc. (QTTB) - Multiplikator forward rega marang pendapatan|GeoVax Labs, Inc. (GOVX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan ibioinc.com|Multiplikator forward rega marang pendapatan CARM|Multiplikator Forward P/S XTL Biopharmaceuticals Ltd|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Aditxt Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GRI Bio Inc|XRTX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan HIND|REVB (Revelation Biosciences) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep indaptusrx.com INDP|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|Rasio kapitalisasi marang dodolan sing dikarepake calcimedica.com|Multiplikator Forward P/S AFMD (Affimed N.V.)|Multiplikator Forward P/S Allakos Inc ALLK|HOOK: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan IGMS (IGM Biosciences, Inc.)|ITOS: Multiplikator Forward P/S|OCEA (Ocean Biomedical Inc) - Rasio rega marang prakiraan pendapatan|TCBP (TC BioPharm (Holdings) PLC) - Multiplikator Forward P/S|Third Harmonic Bio Inc (THRD) - Rasio kapitalisasi marang dodolan sing dikarepake
